News Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 11:35:03 2025-12-12 am EST			5-day change	1st Jan Change
10.79 ^EUR	+0.84%		+0.37%	+17.95%

Dec. 04	Grifols achieves self-sufficiency in plasma-derived medicines in Egypt	RE
Dec. 03	European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	MT

Grifols achieves self-sufficiency in plasma-derived medicines in Egypt	Dec. 04	RE
Grifols S A : Egypt achieves self-sufficiency in plasma-derived medicines thanks to Grifols	Dec. 04	PU
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	Dec. 03	MT
Grifols S A : appoints Tomás Dagá as Vice President of the board of Egypt (GEPD) and accelerates plasma self-sufficiency for 2026	Nov. 27	PU
Grifols Says it Gets US FDA's Expanded Indication for Thrombate III for Pediatric Patients	Nov. 18	MT
Grifols gets FDA approval for Thrombate III in pediatric patients in U.S.	Nov. 18	RE
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading	Nov. 14	MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading	Nov. 13	MT
Grifols gets regulatory approval for fibrinogen concentrate in Germany	Nov. 13	RE
Grifols S A : ’ Biotest receives first regulatory approval for its fibrinogen concentrate	Nov. 13	PU
Spanish stocks - Factors to watch on Nov 13	Nov. 13	RE
Grifols secures 95% of investor support to improve documentation terms of its 1.3 bln euros secured notes	Nov. 12	RE
Grifols S A : Secures 95% of Investor Support to Improve Documentation Terms of Its €1.3 Billion 7.5% Secured Notes	Nov. 12	PU
Grifols S A : Secures 95% of Investor Support to Improve Documentation Terms of Its €1.3 Billion 7.5% Secured Notes November 12 2025	Nov. 12	PU
Grifols S A : Consent Solicitation Results Announcement	Nov. 12	PU
Grifols S A : Revocation Deadline Announcement	Nov. 11	PU
Grifols S A : Welcomes Fitch Ratings’ Outlook Revision to Positive and Affirmation of 'B+' Rating	Nov. 07	PU
Grifols S A : Welcomes Fitch Ratings’ Outlook Revision to Positive and Affirmation of 'B+' Rating November 7 2025	Nov. 07	PU
Fitch Maintains Grifols' Ratings, Changes Outlook to Positive	Nov. 07	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Nov. 06	MT
Grifols lifts 2025 targets but fibrinogen delay and forex drag weigh on outlook	Nov. 06
Grifols, S.A., Q3 2025 Earnings Call, Nov 04, 2025	Nov. 05
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	Nov. 05	MT
Grifols S A : Conference call transcript (71fa8c6b 43e9 afc3 ba4d 858281be78a3t1762349318448)	Nov. 05	PU
Invest Securities raises target price for Grifols	Nov. 05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Grifols lifts 2025 targets but fibrinogen delay and forex drag weigh on outlook

November 06, 2025 at 05:01 am EST

Gotham City sets its sights on Grifols

January 09, 2024 at 10:09 am EST